Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
| All Releases |
|---|
 |
Corgentech Begins Phase I/II Trial of E2F Decoy for Prevention of AV Graft Failure in Patients With End-Stage Renal Disease
May 18, 2004
|
73.2 KB
|
| |
SOUTH SAN FRANCISCO, Calif., May 18, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc., (Nasdaq: CGTK), a biotechnology company, today announced that patient enrollment has begun in the Phase I/II study of E2F Decoy (edifoligide) for the prevention of arterio-venous (AV) graft failure in patients with end-stage renal disease who require h...
|
|
|
Corgentech Announces New Centers for Medicare & Medicaid Services Procedure Code May Apply to E2F Decoy
May 14, 2004
|
71.5 KB
|
| |
SOUTH SAN FRANCISCO, Calif., May 14, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that the Centers for Medicare & Medicaid Services (CMS), a Federal agency within the U.S. Department of Health and Human Services, has published a new ICD-9-CM procedure code for "pressurized trea...
|
|
|
Corgentech to Present at Deutsche Bank's 29th Annual Health Care Conference
Apr 30, 2004
|
67.6 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Apr 30, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that John McLaughlin, the company's president and chief executive officer, will present at Deutsche Bank's 29th Annual Health Care Conference. The five-minute presentation, followed by a 20-minut...
|
|
|
Corgentech Announces First Quarter 2004 Financial Results
Apr 29, 2004
|
81.2 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Apr 29, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK) today reported financial results for the first quarter ended March 31, 2004.
"In addition to successfully completing an initial public offering, we continued to make progress developing our lead product candidate, E2F Decoy, which has...
|
|
|
Corgentech to Announce First Quarter 2004 Results and Host Conference Call on April 29, 2004
Apr 21, 2004
|
67.1 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Apr 21, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, will announce financial results for the first quarter 2004 ended March 31, 2004 after the markets close on Thursday, April 29, 2004. Management will hold a teleconference at 2:00 p.m. PDT/ 5:00 p.m. EDT on April...
|
|
|
Click here to download our most recent fact sheet.